A meta-analysis of combination therapy versus single-agent therapy in anthracycline- and taxane-pretreated metastatic breast cancer: results from nine randomized Phase III trials

DOI: 10.2147/OTT.S101423

Keywords: breast cancer, anthracyclines, chemotherapy, combination therapy, toxicity

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text